Differential expression patterns of the insulin-like growth factor 2 gene in human colorectal cancer

Tumor Biology

Volumn 25, Issue 1-2, 2004, Pages 62-68

  Li, Shu Rui ^a,b   Fai, Chung ^a   Ng, Jeremy ^a   Banerjea, Ayan ^a   Ahmed, Shafi ^a   Hands, Rebecca ^a   Powar, Michael ^a   Ogunkolade, William ^a   Dorudi, Sina ^a   Bustin, Stephen A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Genomic imprinting; Insulin like growth factor 2; Liver metastasis; Microsatellite instability

Indexed keywords

SOMATOMEDIN B;

ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; LIVER METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECTUM MUCOSA; TISSUE LEVEL;

EID: 3042691608     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077725     Document Type: Article

References (46)

1. Ruers T, Bleichrodt RP: Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-1033.
2. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 1990;77:1241-1246.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
4. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, et al: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999;96:6745-6750.
5. Ilyas M, Straub J, Tomlinson IP, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer 1999;35:1986-2002.
6. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
7. Seely BL, Reichart DR, Staubs PA, Jhun BH, Hsu D, Maegawa H, et al: Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J Biol Chem 1995;270:19151-19157.
8. Zarrilli R, Pignata S, Romano M, Gravina A, Casola S, Bruni CB, et al: Expression of insulinlike growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differ 1994;5:1085-1091.
9. Kornfeld S: Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 1992;61:307-330.
10. Oka Y, Rozek LM, Czech MP: Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 1985;260:9435-9442.
11. Guo YS, Narayan S, Yallampalli C, Singh P: Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 1992;102:1101-1108.
12. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, et al: The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997;57:1851-1854.
13. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, et al: Gene expression profiles in normal and cancer cells. Science 1997;276:1268-1272.
14. Notterman DA, Alon U, Sierk AJ, Levine AJ: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-3130.
15. Lambert S, Vivario J, Boniver J, Gol-Winkler R: Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer 1990;46:405-410.
16. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, et al: Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169-6173.
17. Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST: Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 2000;83:1344-1350.
18. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 2001;98:591-596.
19. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002;416:552-556.
20. Reik W, Murrell A: Genomic imprinting. Silence across the border. Nature 2000;405:408-409.
21. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP: Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002;62:6442-6446.
22. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP: Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998;4:1276-1280.
23. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-561.
24. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, et al: Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997;57:3370-3374.
25. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
26. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, et al: Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-5852.
27. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998;95:6870-6875.
28. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, et al: Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998;95: 8698-8702.
29. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-1225.
30. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J Mol Endocrinol 2002;29:23-39.
31. Li SR, Gyselman VG, Lalude O, Dorudi S, Bustin SA: Transcription of the inositol polyphosphate 1-phosphatase gene (INPP1) is upregulated in human colorectal cancer. Mol Carcinog 2000;27:322-329.
32. Tadokoro K, Fujii H, Inoue T, Yamada M: Polymerase chain reaction (PCR) for detection of ApaI polymorphism at the insulin like growth factor II gene (IGF2). Nucleic Acids Res 1991;19:6967.
33. Takano Y, Shiota G, Kawasaki H: Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 2000;59:210-216.
34. Rasheed ZA, Saleem A, Ravee Y, Pandolfi PP, Rubin EH: The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp Cell Res 2002;277:152-160.
35. Salomon DS, Bianco C, De Santis M: Cripto: A novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays 1999;21:61-70.
36. Brown EH, Iqbal MA, Stuart S, Hatton KS, Valinsky J, Schildkraut CL: Rate of replication of the murine immunoglobulin heavy-chain locus: Evidence that the region is part of a single replicon. Mol Cell Biol 1987;7:450-457.
37. Ross DD, Gao Y, Yang W, Leszyk J, Shively J, Doyle LA: The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen. Cancer Res 1997;57:5460-5464.
38. Hansen-Hagge TE, Schafer M, Kiyoi H, Morris SW, Whitlock JA, Koch P, et al: Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 2002;16:2205-2212.
39. Freier S, Weiss O, Eran M, Flyvbjerg A, Dahan R, Nephesh I, et al: Expression of the insulinlike growth factors and their receptors in adenocarcinoma of the colon. Gut 1999;44:704-708.
40. Michell NP, Langman MJ, Eggo MC: Insulinlike growth factors and their binding proteins in human colonocytes: Preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer 1997;76:60-66.
41. Kinouchi Y, Hiwatashi N, Higashioka S, Nagashima F, Chida M, Toyota T: Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 1996;107:105-108.
42. Kawamoto K, Onodera H, Kan S, Kondo S, Imamura M: Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer 1999;85:18-25.
43. Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, et al: Relevance of biologic markers in colorectal carcinoma: A comparative study of a broad panel. Cancer 2002;94:647-657.
44. Remacle-Bonnet MM, Culouscou JM, Garrouste FL, Rabenandrasana C, Marvaldi JL, Pommier GJ: Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line. J Clin Endocrinol Metab 1992;75:609-616.
45. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038.
46. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, et al: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996;14:255-257.